A qualitative examination of apathy and physical activity in Huntington's and Parkinson's disease

Kelly J Atkins; Ciarán P Friel; Sophie C Andrews; Trevor T-J Chong; Julie C Stout; Lori Quinn

doi:10.2217/nmt-2021-0047

Back

A qualitative examination of apathy and physical activity in Huntington's and Parkinson's disease

Journal article

Open access

Peer reviewed

A qualitative examination of apathy and physical activity in Huntington's and Parkinson's disease

Kelly J Atkins, Ciarán P Friel, Sophie C Andrews, Trevor T-J Chong, Julie C Stout and Lori Quinn

Neurodegenerative Disease Management, Vol.12(3), pp.129-139

2022

DOI: https://doi.org/10.2217/nmt-2021-0047

PMID: 35412856

Files and links (2)

pdf

A qualitative examination of apathy and physical activity in Huntington's and Parkinson's disease1.33 MBDownload View

Published VersionCC BY V4.0, Open Access

url

https://doi.org/10.2217/nmt-2021-0047View

Published Version

Abstract

apathy

fatigue

Huntington disease

intervention

motivation

Parkinson disease

physical activity

Aim: In Huntington's disease (HD) and Parkinson's disease (PD), apathy is a frequently cited barrier to participation in physical activity. Current diagnostic criteria emphasize dissociable variants of apathy that differentially affect goal-directed behavior. How these dimensions present and affect physical activity in HD and PD is unknown. Methods: Using a qualitative approach, we examined the experience of apathy and its impact on physical activity in 20 people with early-manifest HD or idiopathic PD. Results: Two major themes emerged: the multidimensionality of apathy, including initiation or goal-identification difficulties, and the interplay of apathy and fatigue; and facilitators of physical activity, including routines, safe environments and education. Conclusion: Physical activity interventions tailored to apathy phenotypes may maximize participant engagement.

Details

Title: A qualitative examination of apathy and physical activity in Huntington's and Parkinson's disease
Authors: Kelly J Atkins (Author) - Monash University
Ciarán P Friel (Author) - Feinstein Institute for Medical Research
Sophie C Andrews (Author) - Monash University
Trevor T-J Chong (Author) - Monash University
Julie C Stout (Author) - Monash University
Lori Quinn (Author) - Columbia University
Publication details: Neurodegenerative Disease Management, Vol.12(3), pp.129-139
Publisher: Future Medicine Ltd.
Date published: 2022
DOI: 10.2217/nmt-2021-0047
ISSN: 1758-2032; 1758-2024
PMID: 35412856
Copyright note: Copyright (c) 2022. This work is licensed under the Creative Commons Attribution 4.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Organisation Unit: University of the Sunshine Coast, Queensland; Thompson Institute
Language: English
Record Identifier: 99659598102621
Output Type: Journal article

Metrics

154 File views/ downloads

34 Record Views

6 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Web Of Science research areas: Clinical Neurology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites